Literature DB >> 2934334

The differential impact of copayment on drug use in a Medicaid population.

C E Reeder, A A Nelson.   

Abstract

In this study of the influence of copayment on drug utilization, we examined the prescription experience of 10 categories of drugs used by Medicaid beneficiaries in South Carolina over a four-year period. We observed an immediate and significant effect of copayment on the level of expenditures for all drug categories except analgesics and sedative/hypnotic drugs. The impact of copayment on the changes in the slopes of the series was not as dramatic. Only expenditures for cardiovascular, cholinergic, diuretic, and psychotherapeutic agents demonstrated a significant change in the long-term trend. We conclude that the imposition of a copayment for prescription services exerted a differential effect among therapeutic categories.

Mesh:

Year:  1985        PMID: 2934334

Source DB:  PubMed          Journal:  Inquiry        ISSN: 0046-9580            Impact factor:   1.730


  26 in total

1.  Effects of cost sharing on care seeking and health status: results from the Medical Outcomes Study.

Authors:  M D Wong; R Andersen; C D Sherbourne; R D Hays; M F Shapiro
Journal:  Am J Public Health       Date:  2001-11       Impact factor: 9.308

Review 2.  The effect of managed care on prescription drug costs and benefits.

Authors:  A Lyles; F B Palumbo
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

Review 3.  Pharmaceutical policies in Canada. Issues and challenges.

Authors:  D E Angus; H M Karpetz
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

4.  Economic impact of cost-containment strategies in third party programmes in the US (part I).

Authors:  C E Reeder; E W Lingle; R M Schulz; R P Mauch; B S Nightengale; C A Pedersen; M L Watrous; S E Zetzl
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

5.  Prescription cost sharing: economic and health impacts, and implications for health policy.

Authors:  R A Levy
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

Review 6.  A framework for cost-sharing policy analysis.

Authors:  R J Rubin; D N Mendelson
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

Review 7.  Pharmacy utilization and the Medicare Modernization Act.

Authors:  Vittorio Maio; Laura Pizzi; Adam R Roumm; Janice Clarke; Neil I Goldfarb; David B Nash; David Chess
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

8.  Practitioners and health policy. Case of the Ontario Drug Benefit Plan.

Authors:  S E Shortt
Journal:  Can Fam Physician       Date:  1995-12       Impact factor: 3.275

9.  The effect of pharmacy benefit design on patient-physician communication about costs.

Authors:  William H Shrank; Sarah A Fox; Adele Kirk; Susan L Ettner; Clairessa H Cantrell; Peter Glassman; Steven M Asch
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

10.  Steering without navigation equipment: the lamentable state of Australian health policy reform.

Authors:  Jeff Rj Richardson
Journal:  Aust New Zealand Health Policy       Date:  2009-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.